http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014302540-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00aace35635eba7742e68b5e9d730cb4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-60 |
filingDate | 2012-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7393a0703d26135c4c5d1830b6c57d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_795f65a3cfe91410bdd63a8f7c0c772c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e8ccc3ed322e3af12a750b744fa09f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e2e8383bcc208187f1d8f0df2bd07e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5d47d2a66d830889b26d513b6cd2480 |
publicationDate | 2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2014302540-A1 |
titleOfInvention | Blood sample assay method |
abstract | The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component. The method includes: i) diluting the sample with a reagent mixture; ii) substantially removing blood cells; iii) using a reagent which serves to temporarily prevent reaction of the second component, to generate a blocked second component; iv) causing the selective reaction of a constituent of each analyte to directly or indirectly generate detectable reaction products, where one of the analytes is the first component; v) monitoring the detectable reaction product or products; vi) relating an amount of the detectable product or products and/or a rate of formation of the detectable product or products to the concentration of each analyte, where the concentration of at least the first component is related to a corresponding detectable reaction product by means of estimating an un-measurable (fictive) endpoint. Step iii) may be carried out at any stage up to and including step iv) but before steps v) or vi). The reagent of step iii) may be applied to the sample separately or may be included in a reagent mixture during steps i) or iv). A corresponding kit is also provided. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017106769-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112695071-A |
priorityDate | 2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 889.